1. Home
  2. JFIN vs PMI Comparison

JFIN vs PMI Comparison

Compare JFIN & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JFIN

Jiayin Group Inc.

HOLD

Current Price

$4.70

Market Cap

223.6M

Sector

Finance

ML Signal

HOLD

PMI

Picard Medical Inc.

N/A

Current Price

$0.96

Market Cap

202.7M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
JFIN
PMI
Founded
2011
1981
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
223.6M
202.7M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
JFIN
PMI
Price
$4.70
$0.96
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
85.2K
106.0K
Earning Date
06-03-2026
03-25-2026
Dividend Yield
17.70%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$1.35
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.70
$0.92
52 Week High
$18.70
$13.68

Technical Indicators

Market Signals
Indicator
JFIN
PMI
Relative Strength Index (RSI) 43.95 39.62
Support Level $3.70 $0.92
Resistance Level $7.22 $1.37
Average True Range (ATR) 0.30 0.08
MACD 0.07 0.01
Stochastic Oscillator 75.38 22.18

Price Performance

Historical Comparison
JFIN
PMI

About JFIN Jiayin Group Inc.

Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.

About PMI Picard Medical Inc.

Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.

Share on Social Networks: